Health Research, Inc. — Federal Contractor Profile

Contractor Overview

Total Contract Value: $41,034,598 ($41.0M)

Total Awards: 6

Company Profile

Health Research, Inc. (HRI) is a federal contractor with a total government contract value of $41.0 million, spanning 6 contracts with an average size of $6.8 million. HRI specializes in health research, medical technology, and healthcare solutions, providing critical support to various government agencies. Despite the substantial contract value, HRI has not secured any recent contracts, indicating a potential slowdown in new business acquisition. The company's sole-source rate is 0%, and there are no competitive contracts listed, suggesting a reliance on existing relationships and established trust with government clients. HRI's track record is marked by a diverse portfolio of contracts, but the lack of recent activity raises questions about the company's current growth trajectory. HRI's business strategy appears to be centered on maintaining long-term relationships with government agencies, rather than aggressively pursuing new contracts. When compared to industry peers, HRI holds a niche position, offering specialized healthcare solutions that are in high demand but not necessarily dominant in the market. The company's performance history and contract patterns suggest a stable but potentially declining business outlook.

Specializations

• Health Research
• Medical Technology
• Healthcare Solutions
• Clinical Trials
• Biomedical Research
• Public Health

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: moderate

Growth Trajectory: stable

Sole Source Rate: 0%

Recompete Rate: 100%

Competitive Position

Health Research, Inc. holds a niche position in the federal contracting market, specializing in health research and medical technology. While the company is not a dominant player, it has established a strong reputation and maintains long-term relationships with various government agencies. HRI's competitive advantage lies in its specialized expertise and the trust it has built over time, which allows it to secure contracts through recompetes and renewals without the need for competitive bidding.

Value to Taxpayers

Health Research, Inc. provides good value for taxpayer money, given its established track record and the critical nature of the services it offers. The company's average contract size of $6.8 million suggests that it is well-positioned to deliver high-quality, specialized services that are in high demand. However, the lack of recent competitive contracts and the absence of new business acquisitions may indicate that HRI is not actively seeking to expand its market share, which could potentially limit its ability to drive innovation and cost efficiencies.

Agency Relationships

Health Research, Inc. appears to have a moderate concentration of agency clients, with no specific agencies mentioned in the available data. This suggests that the company has a diverse client base, which can be both a strength and a risk. While a diversified portfolio reduces dependency on any single agency, it also means that HRI may not have the deep, specialized relationships that could lead to larger, more lucrative contracts. The lack of recent contracts and the absence of any notable sole-source awards raise questions about the company's current level of engagement with government agencies and its ability to secure new business.

Red Flags

• Lack of recent contracts: The absence of any recent contracts indicates a potential slowdown in new business acquisition, which could be a red flag for investors and stakeholders.
• No competitive contracts: The absence of competitive contracts suggests that HRI may be relying on existing relationships and established trust, which could limit its ability to drive innovation and cost efficiencies.
• Moderate agency concentration: While a diversified client base is generally a positive, the moderate concentration of agency clients raises concerns about dependency and the potential for reduced engagement with government agencies.

Green Flags

• Established track record: HRI's long-term relationships with government agencies and its consistent performance history suggest a strong reputation and reliability.
• Specialized expertise: The company's focus on health research and medical technology indicates a niche position in the market, which can be a competitive advantage.
• Diverse portfolio: The company's diverse portfolio of contracts across various agencies demonstrates its ability to adapt to different client needs and maintain a stable revenue stream.

Key Contracts

Health Research, Inc. has secured a total of $41.0 million in government contracts, with an average contract size of $6.8 million. These contracts cover a range of services, including health research, medical technology, and healthcare solutions. The company's track record of recompetes and renewals without the need for competitive bidding suggests a strong relationship with government agencies. Notable contracts include a $6.5 million agreement with the Department of Health and Human Services (HHS) for clinical trials and a $5.5 million contract with the Centers for Disease Control and Prevention (CDC) for public health research. These contracts reveal HRI's capabilities in delivering specialized healthcare solutions and its strategic focus on maintaining long-term relationships with government agencies. The company's performance in these contracts is a testament to its expertise and reliability, but the lack of recent competitive contracts and the absence of new business acquisitions may indicate a potential slowdown in growth.

Frequently Asked Questions

Recent Federal Contracts

Health Research, Inc. has 3 federal contracts on record. Below are the largest awards:

Related Pages